About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
Join Now
Utah Life Sciences News & Events
Corporate Policy and Infectious Disease Response Plan
March 25, 2020
Develop an overriding policy for how the company will respond to a COVID-19 outbreak and impacts. Helpful resources:
Click here
to download a copy of the World Health Organization’s guide to developing a “Strategic Preparedness and Response Plan for the New Coronavirus”
CDC Business and Employer Guidance
Implement a plan of action for counseling employees who are concerned they may have been exposed to the virus.
Identify an HR point of contact
Where to send them to get tested (
https://coronavirus.utah.gov.
)
Policy for self-quarantine
Tracing of exposure to others
Clarify PTO and sick leave policies to encourage employees who are not well to stay home. Paid sick leave should be adjusted to accommodate the response to COVID-19.
Understand that employees may be affected by school closures that will impact child care needs and employee availability.
Plan for business disruptions
Cross Train employees
Identify critical functions to maintain operations.
Examine supply chain vulnerabilities.
Establish a process to communicate information to employees on the company response plan
Coordination with state and local health officials is strongly suggested to ensure appropriate and timely actions and responses.
Recent News
Startups Selected to Pitch at the 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit
RadSep’s Purification and Molecular Recognition Technology
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
Cytiva Sponsors Operational Excellence Case Study Competition
Life Sciences Day on the Hill 2026 — Recap
Fluidx Embolic IDE Trial Results Accepted for Late-Breaking Presentation at the SIR Annual Meeting